Redhill Biopharma Ltd. (RDHL)
Company News
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.25% to 37,900.45 while the NASDAQ fell 0.13% to 15,462.53. The S&P 500 also rose, gaining, 0.19% to 4,877.88. Check This Out: How To Earn $500 A Month From Capital One Financial Ahead Of Its Q4 Earnings Report  Leading and Lagging Sectors  Energy shares rose by 1.7% on Thursday. In trading on Thursday, consumer discretionary shares fell by 1.5%.  Top Headline  American Airlines Group Inc (NASDAQ: AAL) reported better-than-expected fourth-quarter results. American Airlines reported a 75% drop in adjusted earnings to 29 cents per share in the fourth quarter of 2023 but still came in well above the consensus estimate of 10 cents per share. Total revenue decreased 1% to $13.06 billion, just beating estimates of $13.02 billion. American Airlines expects its full-year 2024 adjusted earnings per diluted share of $2.25-$3.25 versus the consensus of $2.25.  Equities Trading UP  Vera Therapeutics, Inc. (NASDAQ: VERA) shares shot up 53% to $25.97 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Shares of Processa ...
Understand how market trends impact penny stocks The post The Impact of Market Trends on Penny Stocks Performance appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
RedHill Biopharma (RDHL) receives a new patent from the United States Patent and Trademark Office for its investigational COVID-19 candidate, opaganib, in COVID-19 patients with pneumonia. Stock up.